Journal Article

Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know

Isabelle Opitz, Raphael Bueno, Eric Lim, Harvey Pass, Ugo Pastorino, Mattia Boeri and Gaetano Rocco

in European Journal of Cardio-Thoracic Surgery

Published on behalf of European Association for Cardio-Thoracic Surgery

Volume 46, issue 4, pages 602-606
Published in print October 2014 | ISSN: 1010-7940
Published online March 2014 | e-ISSN: 1873-734X | DOI: https://dx.doi.org/10.1093/ejcts/ezu048
Biomolecular and clinical practice in malignant pleural mesothelioma and lung cancer: what thoracic surgeons should know

More Like This

Show all results sharing these subjects:

  • Cardiothoracic Anaesthesia
  • Respiratory Medicine and Pulmonology
  • Cardiothoracic Surgery
  • Professional Development in Medicine

GO

Show Summary Details

Preview

Today, molecular-profile-directed therapy is a guiding principle of modern thoracic oncology. The knowledge of new biomolecular technology applied to the diagnosis, prognosis, and treatment of lung cancer and mesothelioma should be part of the 21st century thoracic surgeons' professional competence. The European Society of Thoracic Surgeons (ESTS) Biology Club aims at providing a comprehensive insight into the basic biology of the diseases we are treating. During the 2013 ESTS Annual Meeting, different experts of the field presented the current knowledge about diagnostic and prognostic biomarkers in malignant pleural mesothelioma including new perspectives as well as the role and potential application of microRNA and genomic sequencing for lung cancer, which are summarized in the present article.

Keywords: Malignant pleural mesothelioma; Lung cancer; Biomarker; microRNAs; Genomic sequencing

Journal Article.  4264 words. 

Subjects: Cardiothoracic Anaesthesia ; Respiratory Medicine and Pulmonology ; Cardiothoracic Surgery ; Professional Development in Medicine

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content. subscribe or login to access all content.